Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics

Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013

(2018) Keisha A. Houston et al.   JOURNAL OF UROLOGY

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

(2017) Nicholas D. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predicting Response and Recognizing Resistance: Improving Outcomes in Patients With Castration-resistant Prostate Cancer

(2017) Neal Shore et al.   UROLOGY

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States

(2017) Jim C. Hu et al.   JAMA Oncology

Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

(2015) Ahmedin Jemal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Expected population impacts of discontinued prostate-specific antigen screening

(2014) Roman Gulati et al.   CANCER

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries

(2013) Lan Huang et al.   BIOMETRICAL JOURNAL

Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

(2009) Natasha K. Stout et al.   PHARMACOECONOMICS